Stevia is de gangbare naam voor het zoete (witte) extract (steviolglycosides) uit de bladeren van Stevia rebaudiana. Stevia wordt in toenemende mate gebruikt als calorievrije suikervervanger in voeding en dranken. Gezien de gezondheidseffecten van steviolglycosides (met name stevioside) kan stevia een rol spelen bij de preventie en behandeling van metabool syndroom, obesitas, diabetes type 2 en hypertensie.1
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Figuren
Verschenen in
Referenties
Carrera-Lanestosa A et al. Stevia rebaudiana Bertoni: a natural alternative for treating diseases associated with metabolic syndrome. J Med Food. 2017;20(10):933-943.
Geuns JM. Stevioside. Phytochem. 2003;64(5):913-921.
Ye F et al. Modification of stevioside using transglucosylation activity of Bacillus amyloliquefaciens a-amylase to reduce its bitter aftertaste. LWT - Food Sci Technol. 2013;51:524-530.
Goyal SK et al. Stevia (Stevia rebaudiana) a bio-sweetener: a review. Int J Food Sci Nutr. 2010;61(1):1-10.
Anton SD et al. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite. 2010;55(1):37-43.
Scientific Opinion on the safety of steviol glycosides for the proposed uses as a food additive. EFSA Journal 2010;8(4):1537.
Chatsudthipong V et al. Stevioside and related compounds: therapeutic benefits beyond sweetness. Pharmacol Ther. 2009;121(1):41-54.
Latha S et al. Hydroalcoholic extract of Stevia rebaudiana bert. leaves and stevioside ameliorates lipopolysaccharide induced acute liver injury in rats. Biomed Pharmacother. 2017;95:1040-1050.
Kujur RS et al. Antidiabetic activity and phytochemical screening of crude extract of Stevia rebaudiana in alloxan-induced diabetic rats. Pharmacognosy Res. 2010;2(4):258-63.
Philippaert K et al. Steviol glycosides enhance pancreatic beta-cell function and taste sensation by potentiation of TRPM5 channel activity. Nat Commun. 2017;8:14733.
Onakpoya IJ et al. Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials. Eur J Prev Cardiol. 2015;22(12):1575-87.
Jeppesen PB et al. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats. Phytomedicine. 2002;9(1):9-14.
Gregersen S et al. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism. 2004;53:73-76.
Abudula R et al. Rebaudioside Avbdirectly stimulates insulin secretion from pancreatic beta cells: A glucose-dependent action via inhibition of ATP-sensitive K -channels. Diabetes Obes Metab. 2008;10(11):1074–85.
Bhasker S et al. Molecular evidence of insulinomimetic property exhibited by steviol and stevioside in diabetes induced L6 and 3T3L1 cells. Phytomedicine. 2015;22(11):1037-44.
Mohd-Radzman NH et al. Stevioside from Stevia rebaudiana Bertoni increases insulin sensitivity in 3T3-L1 adipocytes. Evid Based Complement Alternat Med. 2013;2013:938081.
Chen J et al. Stevioside counteracts beta-cell lipotoxicity without affecting acetyl CoA carboxylase. Rev Diabet Stud. 2006;3(4):178-88.
Shin DH et al. Glycemic effects of rebaudioside A and erythritol in people with glucose intolerance. Diabetes Metab J 2016;40:283-289.
Sharma N et al. Effect of Stevia extract intervention on lipid profile. Ethno Med. 2009;3:137-140.
Geeraert B et al. Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. Int J Obes. 2010;34:569-577.
Jeppesen PB et al. Antihyperglycemic and blood-pressure reducing effects of stevioside in the diabetic Goto-Kakizaki (GK) rat. Metabolism 2003;52:372-378.
Jeppesen PB et al. Efficacy and tolerability of oral stevioside in patients with type 2 diabetes: a long-term randomized, double-blinded, placebo-controlled study [abstract 0843]. Diabetologia. 2006;49(Suppl 1):511-512.
Maki KC et al. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol. 2008;46(Suppl 7):S47-53.
Chan P et al. A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br J Clin Pharmacol. 2000;50:215-220.
Hsieh MH et al. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. Clin Ther. 2003;25(11):2797-808.
Hsu YH et al. Antihypertensive effect of stevioside in different strains of hypertensive rats. Zhonghua Yi Xue Za Zhi (Taipei). 2002;65(1):1-6.
Liu JC et al. Mechanism of the antihypertensive effect of stevioside in anesthetized dogs. Pharmacology 2003;67:14-20.
Abudula R et al. Rebaudioside A potently stimulates insulin secretion from isolated mouse islets: studies on the dose-, glucose-, and calcium-dependency. Metabolism. 2004;53(10):1378-81.
